For others, the drug improves the kind of test results doctors watch as early warning signs of disease (blood pressure, cholesterol, kidney markers), but the trials that would tell us whether the things we actually care about (heart attacks, strokes, kidney failure) also improve have not yet been reported
Presented for research literature review only Lazi R et al
Made from 100% nonGMO plant sources
Both assays were analyzed in duplicate using a TECAN Infinite M200 plate reader (Tecan Infinite 200, Tecan Group Ltd., Mnnedorf, Switzerland)
Theyre scaling infrastructure, leaning into transparency, and directly challenging pharma dominance